Cancer of Digestive System
Conditions
Keywords
Cachexia, Cancer of Digestive System, Myostatin, Skeletal muscle
Brief summary
Cancer cachexia is responsible for the death of approximately 20% of patients. Myostatin is a master negative regulator of skeletal muscle mass. If the role of myostatin in cancer cachexia is now well established in murine models, no study has focused on muscle expression of Myostatin in relation to the degree of cachexia. the hypothesize is that muscle Myostatin a biological marker of cachexia in patients with cancer of digestive system. The main objective is to compare skeletal muscle Myostatin messenger RiboNucleic Acid (mRNA) level as a function of cachexia in cancer of digestive system patients. Myostatin messenger RiboNucleic Acid (mRNA) level will be determined in a muscle sample taken during the resection under general anaesthesia. Skeletal muscle index will be determined before surgery, 3 and 6 months after surgery. Muscle strength of the lower and upper limbs will be determined before resection, at 1 month, 3 months and 6 months postoperatively. Blood sampling will also be performed on these 4 occasions.
Interventions
DIAGNOSTIC_TESTHeight and weight
Height and weight will be measured to estimate cachexia degree at the time of anaesthetic consultation. (V1)
DIAGNOSTIC_TESTBlood samples
Blood samples will be collected for measuring myostatin on blood at the time of anaesthetic consultation, the day before resection surgery, follow-ups at 1, 3 and 6 months. (V1, V2, V3, V4, V6)
DIAGNOSTIC_TESTSkeletal muscle force
Skeletal muscle force will be determined from Computerized Tomography (CT)-scan at the time of anaesthetic, follow-ups at 1, 3 and 6 months. (V1, V3, V4, V6)
DIAGNOSTIC_TESTSkeletal muscle index
Skeletal muscle index will be determined from Computerized Tomography (CT)-scan at the time of anaesthetic, follow-ups at 1, 3 and 6 months. (V1, V3, V4, V6)
DIAGNOSTIC_TESTMuscle biopsy
Muscle biopsy will be performed during resection surgery under general anaesthesia. (V2)
Sponsors
Centre Hospitalier Universitaire de Saint Etienne
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
40 Years to 80 Years
Healthy volunteers
No
Inclusion criteria
* Women and men aged 40-80. * Diagnosis for cancer of digestive system requiring surgery with neoadjuvant treatment or not. * Signature of consent * Affiliate or beneficiary of social security
Exclusion criteria
* Administration of corticosteroids. * Thyroid disease treated. * Severe chronic pathology during treatment (neuro-muscular pathologies, renal insufficiency requiring dialysis, COPD under continuous oxygen therapy). * Psychological, familial, social or geographical conditions that could affect the participation of the subject throughout the duration of the protocol. * BMI\> 30 due to the difficulty of interpretation of BMI variations in obese patients
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Correlation between skeletal muscle and degree myostatin | Day 1 | Evaluate correlation between skeletal muscle force/index and degree myostatin. Skeletal muscle force/index will be determinated by skeletal muscle force/index results. Degree myostatin will be determinated by blood samples with Enzyme Linked ImmunoSorbent Assay (ELISA) method. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Correlation between skeletal muscle force and index before resection surgery | Baseline from 7 months | Evaluate Correlation between skeletal muscle force and index before resection surgery to estimate the extent of cachexia-induced muscle dysfunction by results tests. |
| Correlation between level of myostatin muscular expression and degree myostatin | Month 2 | Evaluate correlation between level of myostatin muscular expression and degree myostatin. Level of myostatin muscular expression will be determinated by muscle biopsy. Degree myostatin will be determinated by blood samples with Enzyme Linked ImmunoSorbent Assay (ELISA) method. |
| Correlation between level of myostatin muscular expression and skeletal muscle force and index after resection surgery | Month 2 | Determinate correlation between level of myostatin muscular expression and skeletal muscle force and index after resection surgery. |
| Analysis level of myostatin muscular expression and blood samples results | Month 2 | Analysis level of myostatin muscular expression and blood samples results according to cancer stage, neoadjuvant treatment and chemotherapy. |
Countries
France
Outcome results
None listed